The transient elastography devices market has been growing rapidly over the past decade due to the increasing prevalence of chronic liver diseases globally. Transient elastography devices provide non-invasive assessment of liver fibrosis and stiffness withoutopsy. These devices use transient ultrasound pulses to measure tissue elasticity which helps in diagnosis and disease progression monitoring of conditions like hepatitis, non-alcoholic steatohepatitis (NASH), and liver cirrhosis. Some of the key advantages of transient elastography devices include high reproducibility, painless procedure, lack of ionizing radiation exposure and ability to provide real-time results.

The global transient elastography devices market is estimated to be valued at US$ 102.68 KT in 2024 and is expected to exhibit a CAGR of 1.9% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the transient elastography devices market are Echosens, HISKY Medical Technologies Co., Ltd. and SMEDA Medical Co., Ltd. Echosens holds a major market share with its FibroScan product. These players are focusing on new product launches and geographic expansion to consolidate their market position.

The growing burden of chronic liver diseases globally is driving significant demand for Transient Elastography Devices Market Demand . According to the World Health Organization, nearly 1.03 million people die each year from hepatitis related complications indicating need for improved diagnosis.

Major players are also targeting emerging Asian and Latin American markets to tap the opportunities arising from increasing healthcare investments and demand in these regions. The Asia Pacific transient elastography devices market is projected to grow at highest CAGR during the forecast period.

Get more insights on This Topic- Transient Elastography Devices Market